Here are four things to know.
1. North America led the global healthcare nanotechnology market in 2016 and is expected to grow at a compound annual growth rate of 10 percent during the forecasted period.
2. The Asia-Pacific region excluding Japan is the second fastest-growing region, and is expected to expand at a compound annual growth rate of 9.8 percent over the forecasted period.
3. The active implantable devices segment is the fastest growing segment dominating the global market by product type; the biochips segment is forecasted to rise at a compound annual growth rate of 9.6 percent.
4. Key players in the global healthcare nanotechnology market include Thermo Fisher Scientific, Stryker, Smith & Nephew, PerkinElmer, Merck, GE Global Research, Ferro Corp, AstraZeneca, Abbott Laboratories and 3M.
More articles on surface technology:
The future is PEEK – Solvay’s Global Marketing Manager discusses the benefits of polymers
Nanovis’ new spinal implant technology may reduce antibiotic resistance — here’s how
